Dad-Hero

Translating today's discoveries in childhood cancer research into tomorrow's treatments.

Greehey Children’s Cancer Research Institute is only one of two institutes in the United States dedicated solely to pediatric cancer research. Its 20 laboratories focus their strengths in cancer genomics, DNA repair, RNA biology, and drug development on finding new and less toxic treatments for childhood cancers.

Our research strengths include cancer genomics, DNA damage, RNA biology, and drug development. We are developing expertise in drug delivery, with a focus on the nanotechnology-driven delivery of small RNA mimics and inhibitors.

Learn More


Help Make a Difference

Top stories

HHOW 175x225

UT Health San Antonio Gears up to Fight Childhood Cancer, Thanks to Hyundai Hope on Wheels® Grants. (Tomlinson, Kurmasheva)

Allison Grimes MD

Allison Grimes, M.D., MSCI, Awarded $999K CPRIT Grant to Study “Expansion of HPV Vaccination Among Survivors of Childhood Cancer”

content_A105949_NCOM_Sep_2021_journal_cover__1___1_

Nature Communications: Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer (Zheng, Grimes, Lai, Chen, Wang, Tomlinson, Houghton, & Kurmasheva Labs)

m_cover

Nucleic Acids Research: TATDN2 resolution of R-loops is required for the survival of BRCA1-mutant cancer cells (Sung, Gupta, Pertsemlidis, Bishop, et al)